FDA.reportPublic FDA data

MEKTOVI 15 MG Oral Tablet

RxCUI
2049133
RxNorm name
MEKTOVI 15 MG Oral Tablet
Display name
MEKTOVI 15 MG Oral Tablet
Full name
MEKTOVI 15 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MEKTOVIBINIMETINIBArray BioPharma Inc.6c3408ac-d401-4925-8a03-26591afbc2402025-03-20Warnings, Adverse reactionsExact identifier
rxcui: 2049133

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6c3408ac-d401-4925-8a03-26591afbc240MEKTOVI 15 MG Oral Tablet [PSN] · binimetinib 15 MG Oral Tablet [Mektovi] [SBD] · Mektovi 15 MG Oral Tablet [SY]312These highlights do not include all the information needed to use MEKTOVI safely and effectively. See full prescribing information for MEKTOVI. MEKTOVI ® (binimetinib) tablets, for oral use Initial U.S. Approval: 201820250320